EMM Disclosure
February 19 2003 - 6:08AM
UK Regulatory
RNS Number:6938H
Goldman Sachs International
19 February 2003
EMM DISCLOSURE
FORM 38.5 (SUMMARY)
Lodge with a RIS and the Takeover Panel. Use a separate form for each class of
securities in which dealings have been made.
CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM
Goldman Sachs International
Date of disclosure
19 February 2003
Contact name
Stuart Mclerie
Telephone number
+44 207-774-8136
Please see attached disclosure of dealings under Rule 38.5 in the securities of
the following companies:
Oxford Glycosciences plc
Cambridge Antibody Technology plc
AMENDMENT
If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:
In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.
For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.
Email: monitoring@disclosure.org.uk
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Oxford Glycosciences plc
Class of security
Contract For Differences Expiration 22 January 2013
Date of disclosure
19 February 2003
Date of dealing
17 February 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
70,000 (customer sold to close)
Highest price paid*
1.857771 # Sterling
Lowest price paid*
1.857771 # Sterling
Total number of securities sold
Highest price received*
Lowest price received*
*Currency must be stated
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Cambridge Antibody Technology plc
Class of security
Contract For Differences Expiration 22 January 2013
Date of disclosure
19 February 2003
Date of dealing
17 February 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
Highest price paid*
Lowest price paid*
Total number of securities sold
25,522 (customer bought to close)
Highest price received*
4.605518 # Sterling
Lowest price received*
4.605518 # Sterling
*Currency must be stated
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMNKCKKBBKDABD